Variables | At baseline | After treatment | t value | p |
---|---|---|---|---|
CD3 (%) | 63.6 ± 9.0 | 64.7 ± 8.9 | − 1.1 | N.S. |
CD4 (%) | 39.9 ± 5.9 | 39.9 ± 6.0 | .0 | N.S. |
CD8 (%) | 23.8 ± 5.8 | 24.8 ± 5.4 | − 2.2 | .03. |
CD4/CD8 | 1.8 ± .5 | 1.7 ± .4 | 3.3 | .002. |
CD56 (%) | 18.8 ± 7.3 | 19.6 ± 8.7 | − 1.1 | N.S. |
NKCA (%) | 17.0 ± 11.2 | 18.5 ± 11.6 | − 1.0 | N.S. |
HRSD, total | 20.3 ± 5.5 | 11.4 ± 5.2 | 9.1 | < .001 |
Fd | 7.3 ± 2.3 | 4.3 ± 2.3 | 8.4 | < .001 |
Fi | 3.4 ± 1.5 | 1.3 ± 1.5 | 7.8 | < .001 |
Fa | 4.1 ± 1.7 | 2.5 ± 1.4 | 6.0 | < .001 |